Clinical Trial: Clinical Evaluation of the Treatment of Spider Angioma

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Interventional

Official Title: A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy

Brief Summary: To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.

Detailed Summary: The purpose of this study is to evaluate the safety and efficacy of the 532 nm KTP laser within the Cutera Excel V system for the treatment of spider angiomas.
Sponsor: Cutera Inc.

Current Primary Outcome: The investigator will perform a baseline assessment of the spider angiomas and compare the degree of improvement for each treated lesion at 4 weeks post-final treatment using the Physician's Global Assessment scale. [ Time Frame: Four weeks post laser treatment. ]

Original Primary Outcome: Same as current

Current Secondary Outcome: At 4 weeks post-final treatment, subjects will be asked to rate their level of satisfaction with the laser treatment outcome and the overall laser treatment procedure, using the Subject Satisfaction Assessment Scale. [ Time Frame: Four weeks post laser treatment. ]

Original Secondary Outcome: Same as current

Information By: Cutera Inc.

Dates:
Date Received: April 25, 2016
Date Started: April 2016
Date Completion: September 2016
Last Updated: July 25, 2016
Last Verified: April 2016